TTM
$7.02B
YoY change
+36.7%
5Y CAGR
—
Peak year (2017)
$8.11B
Cumulative EBITDA
$70.29B
EBITDA history chart for McKesson (MCK) from 1995 to 2026
Latest: $7.18B
EBITDA growth chart for McKesson (MCK) from 1995 to 2026
Latest: +36.7%
EBITDA history table for McKesson (MCK) from 1995 to 2026
| 2026 | $7.18B | +36.7% | +$1.93B | ||
| 2025 | $5.25B | +12.5% | +$584.00M | ||
| 2024 | $4.67B | -18.6% | −$1.07B | ||
| 2023 | $5.74B | +84.6% | +$2.63B | ||
| 2022 | $3.11B | -186.4% | +$6.70B | ||
| 2021 | −$3.60B | -255.3% | −$5.91B | ||
| 2020 | $2.31B | +27.0% | +$492.00M | ||
| 2019 | $1.82B | +23.8% | +$350.00M | ||
| 2018 | $1.47B | -81.8% | −$6.64B | ||
| 2017 | $8.11B | +80.7% | +$3.62B | ||
| 2016 | $4.49B | +10.9% | +$440.00M | ||
| 2015 | $4.05B | +32.4% | +$991.00M | ||
| 2014 | $3.06B | +11.6% | +$318.00M | ||
| 2013 | $2.74B | +0.7% | +$18.00M | ||
| 2012 | $2.72B | +16.9% | +$393.00M | ||
| 2011 | $2.33B | -7.8% | −$197.00M | ||
| 2010 | $2.52B | +53.1% | +$876.00M | ||
| 2009 | $1.65B | -16.3% | −$321.00M | ||
| 2008 | $1.97B | +16.5% | +$279.00M | ||
| 2007 | $1.69B | +10.7% | +$164.00M | ||
| 2006 | $1.53B | +1151.6% | +$1.41B | ||
| 2005 | $122.00M | -89.9% | −$1.09B | ||
| 2004 | $1.21B | +29.9% | +$278.10M | ||
| 2003 | $929.90M | +2.8% | +$24.90M | ||
| 2002 | $905.00M | +101.0% | +$454.70M | ||
| 2001 | $450.30M | +35.6% | +$118.20M | ||
| 2000 | $332.10M | -37.5% | −$199.40M | ||
| 1999 | $531.50M | +18.3% | +$82.10M | ||
| 1998 | $449.40M | +173.0% | +$284.80M | ||
| 1997 | $164.60M | -52.3% | −$180.80M | ||
| 1996 | $345.40M | +589.4% | +$295.30M | ||
| 1995 | $50.10M | — | — |
- 2026$7.18B+36.7%
- 2025$5.25B+12.5%
- 2024$4.67B-18.6%
- 2023$5.74B+84.6%
- 2022$3.11B-186.4%
- 2021−$3.60B-255.3%
- 2020$2.31B+27.0%
- 2019$1.82B+23.8%
- 2018$1.47B-81.8%
- 2017$8.11B+80.7%
- 2016$4.49B+10.9%
- 2015$4.05B+32.4%
- 2014$3.06B+11.6%
- 2013$2.74B+0.7%
- 2012$2.72B+16.9%
- 2011$2.33B-7.8%
- 2010$2.52B+53.1%
- 2009$1.65B-16.3%
- 2008$1.97B+16.5%
- 2007$1.69B+10.7%
- 2006$1.53B+1151.6%
- 2005$122.00M-89.9%
- 2004$1.21B+29.9%
- 2003$929.90M+2.8%
- 2002$905.00M+101.0%
- 2001$450.30M+35.6%
- 2000$332.10M-37.5%
- 1999$531.50M+18.3%
- 1998$449.40M+173.0%
- 1997$164.60M-52.3%
- 1996$345.40M+589.4%
- 1995$50.10M—
EBITDA values are taken from McKesson's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About EBITDA at McKesson (MCK)
According to McKesson's latest reported financial statements, the company's current EBITDA (TTM) is $7.02B. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
In 2026, McKesson (MCK) EBITDA totalled $7.18B – surged 36.7% year-over-year.
Over 2016–2026 (10 years), McKesson EBITDA expanded at a +4.8% compound annual rate, sustaining 2 straight years of year-over-year growth.
Between 2017 and 2026, McKesson EBITDA declined 11.5%, falling from $8.11B to $7.18B.
$8.11B stands as the all-time-high annual EBITDA, posted in 2017, against a low of −$3.60B during 2021.
McKesson EBITDA by Year
McKesson EBITDA 2026: $7.18B
McKesson posted EBITDA of $7.18B in 2026, surged 36.7% from 2025.
McKesson EBITDA 2025: $5.25B
In 2025, McKesson reported EBITDA of $5.25B, grew 12.5% from 2024.
McKesson EBITDA 2024: $4.67B
McKesson EBITDA in 2024 was $4.67B, declined 18.6% below 2023.
McKesson EBITDA 2023: $5.74B
2023's EBITDA for McKesson came in at $5.74B, surged 84.6% from 2022.
McKesson EBITDA 2022: $3.11B
McKesson EBITDA in 2022 was $3.11B.
See more financial history for McKesson (MCK).
Sector peers by EBITDA
Healthcare peers of McKesson (MCK), ranked by their latest EBITDA
| $41.05B | |
| $28.26B | |
| $27.94B | |
| $24.43B | |
| $23.06B | |
| $19.83B | |
| $17.63B | |
| $16.90B |
- $41.05B
- $28.26B
- $27.94B
- $24.43B
- $23.06B
- $19.83B
- $17.63B
- $16.90B
Frequently asked questions
McKesson (MCK) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation